Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its... see more

CSE:VTAL - Post Discussion

Justera Health Ltd > News : ScreenPro Provides Update on Business Operations
View:
Post by WalkingDead01 on May 10, 2022 4:22am

News : ScreenPro Provides Update on Business Operations

Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that the Company has administered 29,519 Covid-19 tests in April, an increase of 15% compared to March's Covid testing numbers of 25,517. 

With the recent news of Toronto's mayor terminating the Covid-19 emergency declaration that was put in place at the beginning of the pandemic in March 2020 and the surge of cases with the new omicron subvariants world-wide, the Company is confident that Covid testing numbers and market share will continue to increase significantly as testing demand is growing each month within the community. 

"We are pleased that our core business in Covid testing remains strong with an increase of sales in April. As infections continue to trend upwards, we foresee our testing sales to increase further. Management would also like to address the recent news of the SAG AFTRA amendment to stop testing for Zone C (office) and Zone D (postproduction). This news in the film and production industry has minimal effect on our Covid testing business as majority of the testing we administer has been and continues to be for Zone A (cast) and Zone B (crew)," said Lena Kozovski, CEO of the Company.

About ScreenPro

ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs. 

For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.

Comment by lscfa on May 10, 2022 9:07am
  Apr 22 29,519 Mar 2022 25,517 Feb 2022 23,655 Jan 2022 19,446 Dec 2021 14,202 ‘Nov 2021 26,898   & ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities